Function
Locations
Provides UDP-glucose, the activated glucosyl donor for glycogen synthesis (and for galactose/Leloir metabolism, glycosylation and glucuronidation). Deficiency causes developmental and epileptic encephalopathy 83.
Glycogen biosynthesis is the cytosolic pathway that builds the branched glucose polymer glycogen from the activated sugar donor UDP-glucose, storing glucose for later mobilisation. Four steps: UDP-glucose pyrophosphorylase (UGP2) activates glucose-1-phosphate with UTP to form UDP-glucose + pyrophosphate; glycogenin (GYG1) primes synthesis by autoglucosylating a specific tyrosine, using UDP-glucose to build a short covalently-attached alpha-1,4-glucan (~8-12 residues) that nucleates the granule; glycogen synthase (muscle GYS1, liver GYS2) then elongates the chain by processively adding UDP-glucose-derived glucose units in alpha-1,4 linkage; and the glycogen branching enzyme (GBE1) transfers ~6-7-residue segments to internal positions via alpha-1,6 linkages, creating the branches that make glycogen soluble and multiply the non-reducing ends for both synthesis and later degradation. Glycogen synthase is the rate-controlling, tightly regulated step (inhibited by phosphorylation, allosterically activated by glucose-6-phosphate). Inherited defects define disorders across the pathway: UGP2 deficiency causes a developmental and epileptic encephalopathy; GYG1 deficiency causes glycogen storage disease type XV (polyglucosan-body myopathy/cardiomyopathy); GYS2 deficiency causes hepatic glycogen storage disease type 0a (fasting ketotic hypoglycemia) and GYS1 deficiency muscle GSD 0b (cardiomyopathy, sudden death); and GBE1 deficiency causes GSD type IV (Andersen disease) and adult polyglucosan body disease — accumulation of poorly branched, amylopectin-like polyglucosan.
All recommended fields populated.
✗ none found
No MODULE:glycogen_biosynthesis deep-research report alongside the module YAML.
✓ every leaf node grounds to a representative protein.
✓ every declared conforms_to bundle matches its template motif.
5 gene-function check(s) reflected in core functions · 0 conflict(s) · 2 evidence or coverage gap(s) (9 comparison(s))
Retained noncore functions are reported separately; they do not require promotion to core functions. Support from representative genes does not establish conservation across the whole family. Missing reviews or identifiers leave a claim unverified.
| Annoton | Participant | Function | Assessment |
|---|---|---|---|
| ugp2_activity | UGP2 (human) UniProtKB:Q16851 Family Representative |
UTP:glucose-1-phosphate uridylyltransferase activity GO:0003983 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| gyg1_activity | GYG1 (human) UniProtKB:P46976 Family Representative |
glycogenin glucosyltransferase activity GO:0008466 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| gys_activity | GYS1 (human, muscle isoform) UniProtKB:P13807 Family Representative |
alpha-1,4-glucan glucosyltransferase (UDP-glucose donor) activity GO:0004373 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| gys_activity | GYS2 (human, liver isoform) UniProtKB:P54840 Family Representative |
alpha-1,4-glucan glucosyltransferase (UDP-glucose donor) activity GO:0004373 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| gbe1_activity | GBE1 (human) UniProtKB:Q04446 Family Representative |
1,4-alpha-glucan branching enzyme activity GO:0003844 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| ugp2_activity | UTP:glucose-1-phosphate uridylyltransferase family (UGP2) PANTHER:PTHR43511 Family |
UTP:glucose-1-phosphate uridylyltransferase activity GO:0003983 |
Family Supported
Family review supports GO:0003983 FAMILY_WIDE. This is the defining activity of the eukaryotic UDPGP type 1 family. All four modules that use the family assert it, with catalytic representatives: dolichol_phosphate_sugar_donor_supply (as SF4, with UGP1, fyu1 and UGP2), glycogen_metabolism_fungal (UGP1, UGP2), and glycogen_biosynthesis (UGP2). The only exception is the S. pombe paralog SPCC794.10, which PAINT records as diverged. |
| gyg1_activity | Glycogenin family (GYG1/GYG2) PANTHER:PTHR11183 Family |
glycogenin glucosyltransferase activity GO:0008466 |
Family Scope Restricted
GO:0008466 is SUBFAMILY_ONLY; this family grounding does not establish the allowed subfamily scope. Glycogenins only. glycogen_metabolism_fungal and glycogen_biosynthesis select the base family, which also takes in galactinol synthases, GUX and GNT1. Subfamily placements are from the PANTHER 19 classification files; the cached entries carry none. |
| gys_activity | Glycogen synthase family (GYS1/GYS2) PANTHER:PTHR10176 Family |
alpha-1,4-glucan glucosyltransferase (UDP-glucose donor) activity GO:0004373 |
Family Supported
Family review supports GO:0004373 FAMILY_WIDE. Asserted by glycogen_metabolism_fungal and glycogen_biosynthesis on the base family; accepted by every reviewed member in all three subfamilies. |
| gbe1_activity | 1,4-alpha-glucan branching enzyme family (GBE1) PANTHER:PTHR43651 Family |
1,4-alpha-glucan branching enzyme activity GO:0003844 |
Family Scope Restricted
GO:0003844 is SUBFAMILY_ONLY; this family grounding does not establish the allowed subfamily scope. Asserted by glycogen_metabolism_fungal, glycogen_biosynthesis, tres_mak_glge_branched_alpha_glucan_biosynthesis and glycogen_synthesis_and_mobilization; accepted by GLC3. Restricted to the branching-enzyme clade PTN000040010; TreZ (SF11) lacks it. |
4 complete review(s) · 0 with deep research · 0 missing review · 5 reviewed but lacking deep research
| Gene | Review | Complete | Deep research |
|---|---|---|---|
| GBE1 Q04446 | ✓ | 27/28 | ✗ |
| GYG1 P46976 | ✓ | ✓ | ✗ |
| GYS1 P13807 | ✓ | ✓ | ✗ |
| GYS2 P54840 | ✓ | ✓ | ✗ |
| UGP2 Q16851 | ✓ | ✓ | ✗ |
Four-step cytosolic glycogen biosynthesis grounded to the human enzymes UGP2 (UniProtKB:Q16851; GO:0003983, EC 2.7.7.9), glycogenin GYG1 (P46976; GO:0008466, EC 2.4.1.186), glycogen synthase GYS1 (P13807) / GYS2 (P54840) (GO:0004373, EC 2.4.1.11) and branching enzyme GBE1 (Q04446; GO:0003844, EC 2.4.1.18). GO molecular-function terms were taken from the human GOA records; Reactome reaction ids and titles were verified against the local reactome cache. The glycogen-synthase step uses a PANTHER family selector (PTHR10176) generic over GYS1/GYS2 and orthologs, with both human isoforms as representative members; GYG1 (PTHR11183, family also includes GYG2), UGP2 (PTHR43511) and GBE1 (PTHR43651) likewise use family selectors plus a human representative. This is the biosynthetic counterpart of the glycogenolysis module (PYGL/PYGM, AGL, PGM1): glucose-1-phosphate is the shared branch metabolite (PGM1 links the two directions), and glycogenin/synthase form the granule that phosphorylase later degrades. UGP2's UDP-glucose also feeds galactose (Leloir) metabolism and glycosylation (noted, out of scope here). Disorders: UGP2 -> DEE83; GYG1 -> GSD XV; GYS1 -> muscle GSD 0b; GYS2 -> liver GSD 0a; GBE1 -> GSD IV (Andersen) / adult polyglucosan body disease.
Provides UDP-glucose, the activated glucosyl donor for glycogen synthesis (and for galactose/Leloir metabolism, glycosylation and glucuronidation). Deficiency causes developmental and epileptic encephalopathy 83.
Mn2+-dependent, self-glucosylating initiator: builds a short covalently attached alpha-1,4-glucan primer (~8-12 residues on a Tyr) that nucleates the glycogen granule and is elongated by glycogen synthase (with which it forms a complex). Deficiency causes GSD XV (polyglucosan-body myopathy).
Rate-controlling, allosterically- and phosphorylation-regulated enzyme that processively elongates the alpha-1,4 chains from the glycogenin primer using UDP-glucose. Tissue isoforms: GYS1 (muscle, GSD 0b) and GYS2 (liver, GSD 0a).
Introduces the alpha-1,6 branch points by transferring ~6-7-residue segments from a growing alpha-1,4 chain to internal positions, increasing solubility and the number of non-reducing ends. Deficiency causes GSD IV (Andersen disease) and adult polyglucosan body disease.